Tag: Pharmaceuticals
Pharmaceuticals
-
The Open Orphan (ORPH) share price is surging. Should I buy now?
The Open Orphan (ORPH) share price has surged more than 600% in a year. Is it too late to buy? Zaven Boyrazian investigates. More »
-
Have £2,000 to spend? These out-of-favour growth stocks could still help you retire early
Paul Summers takes a look at two acquisition-friendly growth stocks, both of which reported to the market this morning. More »
-
Why I’d stash banking stocks and pharma stocks in my 2018 ISA
Here's why the banking and pharmaceutical sectors could provide great long-term ISA investments. More »
-
Should you invest in banking or pharma stocks for retirement right now?
To me, there’s one clear winner in the banking-versus-pharma stocks debate. More »
-
This promising small-cap stock could be a millionaire maker in 2018
For those willing to take the risk, Paul Summers thinks there could be substantial upside ahead for backers of this small-cap stock. More »
-
Is GlaxoSmithKline plc still a strong buy after Q3 results?
Bilaal Mohamed shares his views on today's third-quarter results from GlaxoSmithKline plc (LON:GSK). More »
-
2 turnaround stocks that could make you rich
Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays. More »
-
Why GlaxoSmithKline plc is the only pharma stock I’d ever own
In a volatile industry, GlaxoSmithKline plc (LON: GSK) stands out for its reliable growth, high dividend and bargain valuation. More »
-
2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc
Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today's announcements? More »
-
This forgotten growth stock deserves more attention
Can this growth stock's "unusual" strategy help it to deliver attractive long-term returns? More »
-
Does cancer breakthrough make this stock a better buy than AstraZenenca plc?
Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm? More »
-
2 safe FTSE 100 shares with dividend yields above 4%
Are these the best FTSE 100 shares for dividends and safety? More »
-
Is this small-cap value stock the next Shire plc?
Could this company become the next Shire plc (LON: SHP) or is it set to fail? More »
-
2 top healthcare shares for growth investors right now
Are these the best healthcare stocks to buy for 2017? More »
-
Better buy: GlaxoSmithKline plc vs Shire plc
Growth and income investors will both find something to cheer with GlaxoSmithKline plc (LON: GSK) and Shire plc (LON: SHP). More »
-
How GlaxoSmithKline plc’s first-mover advantage could power future profits
GlaxoSmithkline plc (LON: GSK) could be looking at its next blockbuster. More »
-
Can these Trump winners extend their gains?
Should you continue to buy these Trump winners? More »
-
Should you ditch these Footsie pharma stocks right now!
Are these blue chips now too dicey to hold? More »
-
Could these top-performing stocks be about to collapse?
Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains. More »
-
2 firms to hold until you retire and beyond
Brexit looks like a sideshow for these enduring businesses. More »